Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Importance of glutamine 189 flexibility in SARS-CoV-2 main protease: Lesson learned from in silico virtual screening of ChEMBL database and molecular dynamics
Mohamed A. Said, Amgad Albohy, Mohamed A. Abdelrahman, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 160, pp. 105744-105744
Open Access | Times Cited: 24

Showing 24 citing articles:

Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58
Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors
Letian Song, Shenghua Gao, Bing Ye, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 1, pp. 87-109
Open Access | Times Cited: 20
Combining In Vitro, In Vivo, and Network Pharmacology Assays to Identify Targets and Molecular Mechanisms of Spirulina-Derived Biomolecules against Breast Cancer
Soha Osama Hassanin, Amany M. Hegab, Reham Hassan Mekky, et al.
Marine Drugs (2024) Vol. 22, Iss. 7, pp. 328-328
Open Access | Times Cited: 8
Exploring the anti-osteoporosis potential of Petroselinum crispum (Mill.) Fuss extract employing experimentally ovariectomized rat model and network pharmacology approach
Noha M. Saeed, Laila Ramadan, Walaa A. El‐Sabbagh, et al.
Fitoterapia (2024) Vol. 175, pp. 105971-105971
Closed Access | Times Cited: 7
Discovery of Pyrano[2,3-c]pyrazole Derivatives as Novel Potential Human Coronavirus Inhibitors: Design, Synthesis, In Silico, In Vitro, and ADME Studies
Abdou K. Allayeh, Aliaa H. El-boghdady, Mohamed A. Said, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 198-198
Open Access | Times Cited: 6
Discovery of potent thieno[2,3-d]pyrimidine VEGFR-2 inhibitors: Design, synthesis and enzyme inhibitory evaluation supported by molecular dynamics simulations
Eman Z. Elrazaz, Rabah A.T. Serya, Nasser S. M. Ismail, et al.
Bioorganic Chemistry (2021) Vol. 113, pp. 105019-105019
Closed Access | Times Cited: 37
In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2
Rahman Abdizadeh, Farzin Hadizadeh, Tooba Abdizadeh
Molecular Diversity (2021) Vol. 26, Iss. 2, pp. 1053-1076
Open Access | Times Cited: 33
Synthesis, antimicrobial, and in silico studies of c5′- O -substituted cytidine derivatives: cinnamoylation leads to improvement of antimicrobial activity
Tahmida Sultana Bhuiyan, Mohamed A. Said, Md Z. H. Bulbul, et al.
Nucleosides Nucleotides & Nucleic Acids (2024), pp. 1-39
Closed Access | Times Cited: 5
2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights
Mostafa M. Elbadawi, Wagdy M. Eldehna, Amer Ali Abd El‐Hafeez, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 37, Iss. 1, pp. 355-378
Open Access | Times Cited: 30
Isatin-pyrimidine hybrid derivatives as enoyl acyl carrier protein reductase (InhA) inhibitors against Mycobacterium tuberculosis
Abdalrahman Khalifa, Amira Khalil, Marwa M. Abdel‐Aziz, et al.
Bioorganic Chemistry (2023) Vol. 138, pp. 106591-106591
Closed Access | Times Cited: 13
Biochemical and molecular docking-based assessment of 's bioactive constituents for their potential application as natural anticancer drug
Ashar H. Khalil, Esraa A. Aidy, Mohamed A. Said, et al.
Algal Research (2024) Vol. 82, pp. 103624-103624
Closed Access | Times Cited: 4
Anti-Inflammatory, Antiallergic, and COVID-19 Main Protease (Mpro) Inhibitory Activities of Butenolides from a Marine-Derived Fungus Aspergillus terreus
İbrahim Seyda Uras, Sherif S. Ebada, Michal Korinek, et al.
Molecules (2021) Vol. 26, Iss. 11, pp. 3354-3354
Open Access | Times Cited: 21
Facilitating SARS CoV-2 RNA-Dependent RNA polymerase (RdRp) drug discovery by the aid of HCV NS5B palm subdomain binders: In silico approaches and benchmarking
Laila K. Elghoneimy, Muhammad I. Ismail, Frank M. Boeckler, et al.
Computers in Biology and Medicine (2021) Vol. 134, pp. 104468-104468
Open Access | Times Cited: 19
Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies
Rahman Abdizadeh, Farzin Hadizadeh, Tooba Abdizadeh
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 13, pp. 5915-5945
Closed Access | Times Cited: 12
Molecular Investigations of Novel Pyrano[2,3-c]Pyrazole Congeners as Potential HCoV-229E Inhibitors: synthesis, Molecular Modeling, 3D QSAR, and ADMET Screening
Mohamed G. Abouelenein, Aliaa H. El-boghdady, Hadeer M. Ali, et al.
Polycyclic aromatic compounds (2024), pp. 1-18
Closed Access | Times Cited: 2
Tackling Microbial Resistance with Isatin-Decorated Thiazole Derivatives: Design, Synthesis, and in vitro Evaluation of Antimicrobial and Antibiofilm Activity
Refaie M. Kassab, Sami A. Al‐Hussain, Nooran S. Elleboudy, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 2817-2832
Open Access | Times Cited: 10
Remdesivir analog as SARS-CoV-2 polymerase inhibitor: virtual screening of a database generated by scaffold replacement
Mohamed A. Said, Amgad Albohy, Mohamed A. Abdelrahman, et al.
RSC Advances (2022) Vol. 12, Iss. 35, pp. 22448-22457
Open Access | Times Cited: 9
Transforming iodoquinol into broad spectrum anti-tumor leads: Repurposing to modulate redox homeostasis
I. CHAABAN, Haidy Hafez, Ibrahim AlZaim, et al.
Bioorganic Chemistry (2021) Vol. 113, pp. 105035-105035
Closed Access | Times Cited: 12
Molecular approaches for extraction and screening of bioactive compounds from forest fungi
Ozioma Forstinus Nwabor, Helen Onyeaka, Ogueri Nwaiwu
Elsevier eBooks (2024), pp. 125-145
Closed Access | Times Cited: 1
Drug repurposing of pyrazolotriazine derivatives as potential anti-SARS-CoV-2 agents: in vitro and in silico studies
Khulood H. Oudah, Mazin A. A. Najm, Reham F. Barghash, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Computational Investigation of Bioactive Phytoconstituents as SarS-Cov-2 Main Protease Inhibitors Through Molecular Docking and Interaction Fingerprint Studies
Galla Rajitha, Vidya Rani Murthi, Yasmintaj Shaik, et al.
Biomedical & Pharmacology Journal (2024) Vol. 17, Iss. 2, pp. 863-880
Open Access
Versatile properties of Opuntia ficus-indica (L.) Mill. flowers: In vitro exploration of antioxidant, antimicrobial, and anticancer activities, network pharmacology analysis, and In-silico molecular docking simulation
Mai Ali Mwaheb, Nashwa Mohamed Reda, Mohammad S. El‐Wetidy, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0313064-e0313064
Open Access
Discovery of Natural-pan Inhibitors by Targeting Snake Venom Secretory Phospholipase A2 through Computational Approaches
Ahmed Mohajja Alshammari
Journal of Advances in Biology & Biotechnology (2022), pp. 30-38
Open Access | Times Cited: 1
Investigation of Neolamarckia cadamba phytoconstituents against SARS-CoV-2 3CL Pro: An In-Silico Approach
Sumit Arora, Kalpana Tirpude, Pallavi Rushiya, et al.
Orbital - The Electronic Journal of Chemistry (2023), pp. 49-56
Open Access
Page 1

Scroll to top